Dissolution and oral absorption of pranlukast nanosuspensions stabilized by hydroxypropylmethyl cellulose

In Hwan Baek, Jung Soo Kim, Eun Sol Ha, Gwang Ho Choo, Wonkyung Cho, Sung Joo Hwang, Min Soo Kim

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The objective of this study was to investigate the effect of particle size on the dissolution and oral absorption of pranlukast microsuspensions and nanosuspensions stabilized by hydroxypropylmethyl cellulose. Four pranlukast suspensions with different mean particle sizes (0.16, 0.89, 3.13, and 18.21μm) were prepared by various top-down processes such as jet milling, high pressure homogenization, and bead milling. The dissolution rate and oral absorption of pranlukast suspensions were significantly affected by the particle size. The in vivo pharmacokinetic parameters of pranlukast suspensions were increased with decreasing mean particle size of suspensions. Especially, the AUC 0→24h and C max values of pranlukast nanosuspension with a particle size of 0.16μm were approximately 3.5- and 6.3-fold greater, respectively, than that of pranlukast microsuspension with a particle size of 18.21μm. Therefore, the preliminary results from our study suggest that a pranlukast nanosuspension with a mean particle size of about 0.16μm may have significant potential for clinical application.

Original languageEnglish
Pages (from-to)53-57
Number of pages5
JournalInternational Journal of Biological Macromolecules
Volume67
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Particle Size
Cellulose
Dissolution
Particle size
Suspensions
Pharmacokinetics
pranlukast
Area Under Curve
Pressure

All Science Journal Classification (ASJC) codes

  • Structural Biology
  • Biochemistry
  • Molecular Biology

Cite this

Baek, In Hwan ; Kim, Jung Soo ; Ha, Eun Sol ; Choo, Gwang Ho ; Cho, Wonkyung ; Hwang, Sung Joo ; Kim, Min Soo. / Dissolution and oral absorption of pranlukast nanosuspensions stabilized by hydroxypropylmethyl cellulose. In: International Journal of Biological Macromolecules. 2014 ; Vol. 67. pp. 53-57.
@article{a45382cd47324262a5ca65d625df57a9,
title = "Dissolution and oral absorption of pranlukast nanosuspensions stabilized by hydroxypropylmethyl cellulose",
abstract = "The objective of this study was to investigate the effect of particle size on the dissolution and oral absorption of pranlukast microsuspensions and nanosuspensions stabilized by hydroxypropylmethyl cellulose. Four pranlukast suspensions with different mean particle sizes (0.16, 0.89, 3.13, and 18.21μm) were prepared by various top-down processes such as jet milling, high pressure homogenization, and bead milling. The dissolution rate and oral absorption of pranlukast suspensions were significantly affected by the particle size. The in vivo pharmacokinetic parameters of pranlukast suspensions were increased with decreasing mean particle size of suspensions. Especially, the AUC 0→24h and C max values of pranlukast nanosuspension with a particle size of 0.16μm were approximately 3.5- and 6.3-fold greater, respectively, than that of pranlukast microsuspension with a particle size of 18.21μm. Therefore, the preliminary results from our study suggest that a pranlukast nanosuspension with a mean particle size of about 0.16μm may have significant potential for clinical application.",
author = "Baek, {In Hwan} and Kim, {Jung Soo} and Ha, {Eun Sol} and Choo, {Gwang Ho} and Wonkyung Cho and Hwang, {Sung Joo} and Kim, {Min Soo}",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.ijbiomac.2014.03.006",
language = "English",
volume = "67",
pages = "53--57",
journal = "International Journal of Biological Macromolecules",
issn = "0141-8130",
publisher = "Elsevier",

}

Dissolution and oral absorption of pranlukast nanosuspensions stabilized by hydroxypropylmethyl cellulose. / Baek, In Hwan; Kim, Jung Soo; Ha, Eun Sol; Choo, Gwang Ho; Cho, Wonkyung; Hwang, Sung Joo; Kim, Min Soo.

In: International Journal of Biological Macromolecules, Vol. 67, 01.01.2014, p. 53-57.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Dissolution and oral absorption of pranlukast nanosuspensions stabilized by hydroxypropylmethyl cellulose

AU - Baek, In Hwan

AU - Kim, Jung Soo

AU - Ha, Eun Sol

AU - Choo, Gwang Ho

AU - Cho, Wonkyung

AU - Hwang, Sung Joo

AU - Kim, Min Soo

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The objective of this study was to investigate the effect of particle size on the dissolution and oral absorption of pranlukast microsuspensions and nanosuspensions stabilized by hydroxypropylmethyl cellulose. Four pranlukast suspensions with different mean particle sizes (0.16, 0.89, 3.13, and 18.21μm) were prepared by various top-down processes such as jet milling, high pressure homogenization, and bead milling. The dissolution rate and oral absorption of pranlukast suspensions were significantly affected by the particle size. The in vivo pharmacokinetic parameters of pranlukast suspensions were increased with decreasing mean particle size of suspensions. Especially, the AUC 0→24h and C max values of pranlukast nanosuspension with a particle size of 0.16μm were approximately 3.5- and 6.3-fold greater, respectively, than that of pranlukast microsuspension with a particle size of 18.21μm. Therefore, the preliminary results from our study suggest that a pranlukast nanosuspension with a mean particle size of about 0.16μm may have significant potential for clinical application.

AB - The objective of this study was to investigate the effect of particle size on the dissolution and oral absorption of pranlukast microsuspensions and nanosuspensions stabilized by hydroxypropylmethyl cellulose. Four pranlukast suspensions with different mean particle sizes (0.16, 0.89, 3.13, and 18.21μm) were prepared by various top-down processes such as jet milling, high pressure homogenization, and bead milling. The dissolution rate and oral absorption of pranlukast suspensions were significantly affected by the particle size. The in vivo pharmacokinetic parameters of pranlukast suspensions were increased with decreasing mean particle size of suspensions. Especially, the AUC 0→24h and C max values of pranlukast nanosuspension with a particle size of 0.16μm were approximately 3.5- and 6.3-fold greater, respectively, than that of pranlukast microsuspension with a particle size of 18.21μm. Therefore, the preliminary results from our study suggest that a pranlukast nanosuspension with a mean particle size of about 0.16μm may have significant potential for clinical application.

UR - http://www.scopus.com/inward/record.url?scp=84896929571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896929571&partnerID=8YFLogxK

U2 - 10.1016/j.ijbiomac.2014.03.006

DO - 10.1016/j.ijbiomac.2014.03.006

M3 - Article

C2 - 24631786

AN - SCOPUS:84896929571

VL - 67

SP - 53

EP - 57

JO - International Journal of Biological Macromolecules

JF - International Journal of Biological Macromolecules

SN - 0141-8130

ER -